Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

Cited by (1,003)

Items 701–800 of 1,003

1. Insulin-like growth factor binding protein 3 (IGFBP-3) potentiates TRAIL-induced apoptosis of human colorectal carcinoma cells through inhibition of NF-κB
   Ann Caroline Williams, H Smartt, Akram H-Zadeh, Marion MacFarlane, C Paraskeva, T J Collard · 2006 · Cell Death and Differentiation
2. DUAL-TARGETED ANTITUMOR EFFECTS AGAINST BRAINSTEM GLIOMA BY INTRAVENOUS DELIVERY OF TUMOR NECROSIS FACTOR-RELATED, APOPTOSIS-INDUCING, LIGAND-ENGINEERED HUMAN MESENCHYMAL STEM CELLS
   Bojie Yang, Xing Wu, Ying Qing Mao, Weiming Bao, Liang Gao, Ping Zhou, Rong Xie, Liangfu Zhou, Jianhong Zhu · 2009 · Neurosurgery
3. ER stress sensitizes cells to TRAIL through down-regulation of FLIP and Mcl-1 and PERK-dependent up-regulation of TRAIL-R2
   Rosa Martín‐Pérez, Maho Niwa, Abelardo López‐Rivas · 2011 · APOPTOSIS
4. Human hepatocellular carcinoma cells resist to TRAIL-induced apoptosis, and the resistance is abolished by cisplatin
   Eui‐Cheol Shin, Young Rim Seong, Chul Hoon Kim, Hoguen Kim, Young Soo Ahn, Kunhong Kim, Se‐Jong Kim, Seung-Suh Hong, Jeon Han Park · 2002 · Experimental & Molecular Medicine
5. Renewed interest in cancer immunotherapy with the tumor necrosis factor superfamily molecules
   Koji Tamada, Lieping Chen · 2005 · Cancer Immunology Immunotherapy
6. Intracellular Mechanisms of TRAIL and Its Role in Cancer Therapy
   Rakesh K. Srivastava · 2000 · Molecular Cell Biology Research Communications
7. Supravital exposure to propidium iodide identifies apoptosis on adherent cells
   Loris Zamai, Barbara Canonico, Francesca Luchetti, Paola Ferri, Elisabetta Melloni, Lia Guidotti, Alessandra Cappellini, Giuseppina Cutroneo, Marco Vitale, Stefano Papa · 2001 · Cytometry
8. Combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and actinomycin D induces apoptosis even in TRAIL-resistant human pancreatic cancer cells.
   Hosei Matsuzaki, Bruno Martin Schmied, Alexis B. Ulrich, Jens Standop, Matthias B. Schneider, Surinder K. Batra, Kathleen S. Picha, Parviz M. Pour · 2001 · PubMed
9. Cytotoxic Activity of Human Dendritic Cells Is Differentially Regulated by Double-Stranded RNA and CD40 Ligand
   Pierre‐Olivier Vidalain, Olga Azocar, Hideo Yagita∥, Chantal Rabourdin‐Combe, Christine Delprat · 2001 · The Journal of Immunology
10. Plasmacytoid Dendritic Cell-Derived IFN-α Induces TNF-Related Apoptosis-Inducing Ligand/Apo-2L-Mediated Antitumor Activity by Human Monocytes Following CpG Oligodeoxynucleotide Stimulation
    Troy J. Kemp, Bennett D. Elzey, Thomas S. Griffith · 2003 · The Journal of Immunology
11. Potential and caveats of TRAIL in cancer therapy
    Jürgen Held, Klaus Schulze‐Osthoff · 2001 · Drug Resistance Updates
12. Activation of the nitric oxide synthase pathway represents a key component of tumor necrosis factor–related apoptosis-inducing ligand–mediated cytotoxicity on hematologic malignancies
    Paola Secchiero, Arianna Gonelli, Claudio Celeghini, Prisco Mirandola, Lia Guidotti, Giuseppe Visani, Silvano Capitani, Giorgio Zauli · 2001 · Blood
13. TIC10/ONC201 synergizes with Bcl-2/Bcl-xL inhibition in glioblastoma by suppression of Mcl-1 and its binding partners in vitro and in vivo
    Georg Karpel‐Massler, Maïmouna Bâ, Chang Shu, Marc‐Eric Halatsch, Mike‐Andrew Westhoff, Jeffrey N. Bruce, Peter Canoll, Markus David Siegelin · 2015 · Oncotarget
14. NF-κB Inhibition Reveals Differential Mechanisms of TNF Versus TRAIL-Induced Apoptosis Upstream or at the Level of Caspase-8 Activation Independent of cIAP2
    Philip Diessenbacher, Mike Hupe, Martin Ronald Sprick, Andreas Kerstan, Peter Geserick, Tobias L. Haas, Tina Wachter, Manfred Neumann, Henning Walczak, John Silke et al. · 2007 · Journal of Investigative Dermatology
15. The histone deacetylase inhibitor, suberoylanilide hydroxamic acid, overcomes resistance of human breast cancer cells to Apo2L/TRAIL
    Lisa M. Butler, Vasilios Liapis, Stelios Bouralexis, Katie J. Welldon, Shelley J. Hay, Le M. Thai, Agatha Labrinidis, Wayne D. Tilley, David M. Findlay, Andreas Evdokiou · 2006 · International Journal of Cancer
16. ENHANCED SENSITIVITY OF BLADDER CANCER CELLS TO TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND MEDIATED APOPTOSIS BY CISPLATIN AND CARBOPLATIN
    Yoichi Mizutani, Masahiro Nakao, Osamu Ogawa, Osamu Yoshida, Benjamin Bonavida, Tsuneharu Miki · 2001 · The Journal of Urology
17. Implication of multiple mechanisms in apoptosis induced by the synthetic retinoid CD437 in human prostate carcinoma cells
    Shi‐Yong Sun, Ping Yue, Reuben Lotan · 2000 · Oncogene
18. Tumor necrosis factor-related apoptosis-inducing ligand in T cell development: Sensitivity of human thymocytes
    Anna Katharina Simon, Owen Williams, Juthathip Mongkolsapaya, Boquan Jin, Xiao Ning Xu, Henning Walczak, Gavin Robert Screaton · 2001 · Proceedings of the National Academy of Sciences
19. Multi-layered nanoparticles for combination gene and drug delivery to tumors
    Asiri Ediriwickrema, Jiangbing Zhou, Yang Deng, W. Mark Saltzman · 2014 · Biomaterials
20. Prognostic Value of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (TRAIL) and TRAIL Receptors in Renal Cell Cancer
    Stephan Macher‐Goeppinger, Sebastian Aulmann, Katrin Elisabeth Tagscherer, Nina Wagener, Axel Haferkamp, Roland Penzel, Antje Brauckhoff, Markus Hohenfellner, Jaromir Sykora, Henning Walczak et al. · 2009 · Clinical Cancer Research
21. Abrogation of constitutive STAT3 activity sensitizes human hepatoma cells to TRAIL-mediated apoptosis
    Mariko Kusaba, Kazuhiko Nakao, Takashi Goto, Daisuke Nishimura, Hiroshi Kawashimo, Hidetaka Shibata, Yasuhide Motoyoshi, Naota Taura, Tatsuki Ichikawa, Keisuke Hamasaki et al. · 2007 · Journal of Hepatology
22. Cooperation of the Agonistic DR5 Antibody Apomab with Chemotherapy to Inhibit Orthotopic Lung Tumor Growth and Improve Survival
    Hongkui Jin, Renhui Yang, Jed Ross, Sharon E. Fong, Richard A.D. Carano, Klára Tótpál, David A. Lawrence, Zhong Zheng, Hartmut Koeppen, Howard Marvin Stern et al. · 2008 · Clinical Cancer Research
23. Mechanisms of Drug Resistance in Relapse and Refractory Multiple Myeloma
    Wen‐Chi Yang, Sheng-Fung Lin · 2015 · BioMed Research International
24. Hypericin photo‐induced apoptosis involves the tumor necrosis factor‐related apoptosis‐inducing ligand (TRAIL) and activation of caspase‐8
    Christoph Mathis Schempp, Birgit Simon-Haarhaus, Christian Termeer, Jan Christoph Simon · 2001 · FEBS Letters
25. Human osteoblasts are resistant to Apo2L/TRAIL-mediated apoptosis
    Gerald J. Atkins, Stelios Bouralexis, Andreas Evdokiou, Shelley J. Hay, Agatha Labrinidis, Andrew C.W. Zannettino, David R. Haynes, David M. Findlay · 2002 · Bone
26. Caspase-2 is activated at the CD95 death-inducing signaling complex in the course of CD95-induced apoptosis
    Inna N. Lavrik, Alexander Golks, Simone Baumann, Peter H. Krammer · 2006 · Blood
27. Expression of Biologically Active Human TRAIL in Transgenic Pigs
    Regina Klose, Elisabeth Kemter, Tanja Bedke, Iris Bittmann, Barbara Keler, Robert Endres, Klaus Pfeffer, Reinhard Schwinzer, Eckhard Wolf · 2005 · Transplantation
28. General Sensitization of Melanoma Cells for TRAIL-Induced Apoptosis by the Potassium Channel Inhibitor TRAM-34 Depends on Release of SMAC
    Sandra-Annika Quast, Anja Berger, Nicole Buttstädt, Kristin Friebel, Roland Schönherr, Jürgen Eberle · 2012 · PLoS ONE
29. Engineering death receptor ligands for cancer therapy
    Harald Wajant, Jeannette Gerspach, Klaus Pfizenmaier · 2011 · Cancer Letters
30. ZD1839 (Gefitinib, ‘Iressa’), an epidermal growth factor receptor‐tyrosine kinase inhibitor, enhances the anti‐cancer effects of TRAIL in human esophageal squamous cell carcinoma
    Fuminori Teraishi, Shunsuke Kagawa, Takanori Watanabe, Yasuhisa Tango, Takeshi Kawashima, Tatsuo Umeoka, Masahiko Nisizaki, Noriaki Tanaka, Toshiyoshi Fujiwara · 2005 · FEBS Letters
31. Death receptors as targets for anti‐cancer therapy
    Kerstin Papenfuss, Stefanie M. Cordier, Henning Walczak · 2008 · Journal of Cellular and Molecular Medicine
32. Tumor cell-selective apoptosis induction through targeting of KV10.1 via bifunctional TRAIL antibody
    Franziska Hartung, Walter Stühmer, Luis A. Pardo · 2011 · Molecular Cancer
33. HuR Contributes to TRAIL Resistance by Restricting Death Receptor 4 Expression in Pancreatic Cancer Cells
    Carmella Romeo, Matthew C. Weber, Mahsa Zarei, Danielle DeCicco, Saswati N. Chand, Angie D. Lobo, Jordan Michael Winter, Janet A. Sawicki, Jonathan N. Sachs, Nicole C. Meisner-Kober et al. · 2016 · Molecular Cancer Research
34. Trail activity in human ovarian cancer cells
    Sara Vignati, Anna Maria Codegoni, Federica Polato, Massimo Broggini · 2002 · European Journal of Cancer
35. Neural Stem Cell Biology May Be Well Suited for Improving Brain Tumor Therapies
    Stephen S. F. Yip, Karen Saida Aboody, Michael Burns, Jaime Imitola, John Andrew Boockvar, Jennifer R. Allport, Kook In Park, Yang Dong Teng, Mahesh B. Lachyankar, Tracy K. McIntosh et al. · 2003 · The Cancer Journal
36. Influence of Casein Kinase II in Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Induced Apoptosis in Human Rhabdomyosarcoma Cells
    Kamel Izeradjene, Leslie Douglas, Addison B. Delaney, Janet A. Houghton · 2004 · Clinical Cancer Research
37. Mitochondria-dependent and -independent mechanisms in tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis are both regulated by interferon-γ in human breast tumour cells
    Carmen Ruiz‐Ruiz, Abelardo López‐Rivas · 2002 · Biochemical Journal
38. TRAIL Receptor and CD95 Signal to Mitochondria via FADD, Caspase-8/10, Bid, and Bax but Differentially Regulate Events Downstream from Truncated Bid
    Arlette B. Werner, Evert de Vries, Stephen W. G. Tait, Ilja Bontjer, Jannie G. Borst · 2002 · Journal of Biological Chemistry
39. Ultraviolet Light Downregulates CD95 Ligand and Trail Receptor Expression Facilitating Actinic Keratosis and Squamous Cell Carcinoma Formation
    Felix Bachmann, Marion Wernli, Sandro Strebel, Peter Erb, Stanislaw A. Buechner · 2001 · Journal of Investigative Dermatology
40. A novel AML-selective TRAIL fusion protein that is superior to Gemtuzumab Ozogamicin in terms of in vitro selectivity, activity and stability
    Bram ten Cate, Edwin Bremer, Marco de Bruyn, Theo Bijma, Douwe Freerk Samplonius, Michael Schwemmlein, Gerwin A. Huls, Georg H. Fey, Wijnand Helfrich · 2009 · Leukemia
41. Apoptosis induced by FasL and TRAIL/Apo2L in the pathogenesis of thyroid diseases
    Nicholas Mitsiades, Vassiliki Poulaki, Constantine S. Mitsiades, Demetrios A. Koutras, George Panagiotis Chrousos · 2001 · Trends in Endocrinology and Metabolism
42. Biochemical Analysis of the Native TRAIL Death-Inducing Signaling Complex
    Henning Walczak, Tobias L. Haas · 2008 · Humana Press eBooks
43. Effect of TNF-α on Raji cells at different cellular levels estimated by various methods
    Vladimir Jurišić, Gordana M. Bogdanovic, Vesna Kojić, Dimitar Jakimov, Tatjana Srdić‐Rajić · 2005 · Annals of Hematology
44. Evidence for Two Modes of Development of Acquired Tumor Necrosis Factor-related Apoptosis-inducing Ligand Resistance
    Jae Jin Song, Jee Young An, Yong Tae Kwon, Yong Jun Lee · 2006 · Journal of Biological Chemistry
45. Augmented Antitumor Activity against B-Cell Lymphoma by a Combination of Monoclonal Antibodies Targeting TRAIL-R1 and CD20
    Sreeram Maddipatla, Francisco J. Hernandez‐Ilizaliturri, Joy Knight, Myron Stefan Czuczman · 2007 · Clinical Cancer Research
46. Oxaliplatin immuno hybrid nanoparticles for active targeting: an approach for enhanced apoptotic activity and drug delivery to colorectal tumors
    Shashank Tummala, K. Gowthamarajan, M. N. Satish Kumar, Ashish Devidas Wadhwani · 2015 · Drug Delivery
47. Increased expression of Mcl‐1 is responsible for the blockage of TRAIL‐induced apoptosis mediated by EGF/ErbB1 signaling pathway
    Elizabeth S. Henson, Erika M. Gibson, Jacylyn Villanueva, Nicolle A. Bristow, Neil Haney, Spencer Bruce Gibson · 2003 · Journal of Cellular Biochemistry
48. Monoclonal antibody to tumor necrosis factor-related apoptosis-inducing ligand receptor 2 (TRAIL-R2) induces apoptosis in primary renal cell carcinoma cells in vitro and inhibits tumor growth in vivo
    Yu Zeng, X. Wu, Michele Fiscella, Osami Shimada, Robin C. Humphreys, Vivian R. Albert, Yoshiyuki Kakehi · 2006 · International Journal of Oncology
49. c-Myc Blazing a Trail of Death: Coupling of the Mitochondrial and Death Receptor Apoptosis Pathways by c-Myc
    Anni I. Nieminen, Johanna I. Partanen, Juha T. Klefström · 2007 · Cell Cycle
50. Differential modulation of the TRAIL receptors and the CD95 receptor in colon carcinoma cell lines
    Caroline M. M. van Geelen, Elisabeth G.E. de Vries, T K P Le, R P van Weeghel, Steven de Jong · 2003 · British Journal of Cancer
51. The Role of Fas-Mediated Apoptosis After Traumatic Spinal Cord Injury
    Osamu Yoshino, Hiroaki Matsuno, Hiroshi Nakamura, Kazuo Yudoh, Yumiko Abe, Takashi Sawai, Miwa Uzuki, Shin Yonehara, Tomoatsu Kimura · 2004 · Spine
52. Compartmentalization of TNF-related apoptosis-inducing ligand (TRAIL) death receptor functions: emerging role of nuclear TRAIL-R2
    Uwe Bertsch, Christian Röder, Holger Kalthoff, Anna Trauzold · 2014 · Cell Death and Disease
53. Fucoxanthin and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Synergistically Promotes Apoptosis of Human Cervical Cancer Cells by Targeting PI3K/Akt/NF-κB Signaling Pathway
    Ye Jin, Shuang Qiu, Na Shao, Jianhua Zheng · 2018 · Medical Science Monitor
54. APO2 ligand/tumor necrosis factor-related apoptosis-inducing ligand in prostate cancer therapy
    Octavian Bucur · 2006 · Frontiers in bioscience
55. Caspase 8-dependent sensitization of cancer cells to TRAIL-induced apoptosis following reovirus-infection
    Penny Clarke, Suzanne M. Meintzer, Aaron C. Spalding, Gary L. Johnson, Kenneth L. Tyler · 2001 · Oncogene
56. Activation of the Proapoptotic Death Receptor DR5 by Oligomeric Peptide and Antibody Agonists
    Bing Li, Stephen J. Russell, Deanne M. Compaan, Klára Tótpál, Scot A. Marsters, Avi Ashkenazi, Andrea G. Cochran, S.G. Hymowitz, Sachdev S. Sidhu · 2006 · Journal of Molecular Biology
57. TRAIL sensitizes for ionizing irradiation-induced apoptosis through an entirely Bax-dependent mitochondrial cell death pathway
    Jana Wendt, Clarissa von Haefen, Philipp Hemmati, Claus Belka, Bernd Dörken, Peter T. Daniel · 2005 · Oncogene
58. Selective induction of apoptosis in leukemic B-lymphoid cells by a CD19-specific TRAIL fusion protein
    Julia Stieglmaier, Edwin Bremer, Christian Kellner, Tanja M. Liebig, Bram ten Cate, Matthias Peipp, Hendrik Schulze‐Koops, Matthias Manuel Pfeiffer, Hans‐Jörg Bühring, Johann Greil et al. · 2007 · Cancer Immunology Immunotherapy
59. Perturbation of the Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Cascade in Ovarian Cancer: Overexpression of FLIPL and Deregulation of the Functional Receptors DR4 and DR5
    Peter Horak, Dietmar Pils, Alexandra Kaider, Alexander Pinter, Katarzyna Elandt, Cornelia Sax, Christoph Carl Zielinski, Reinhard Horvat, Robert Zeillinger, Alexander Reinthaller et al. · 2005 · Clinical Cancer Research
60. Hypoxia Inhibits Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Induced Apoptosis by Blocking Bax Translocation
    Moonil Kim, Sang-Youel Park, Hyun‐Sook Pai, Tae‐Hyoung Kim, Timothy R. Billiar, Dai‐Wu Seol · 2004 · Cancer Research
61. Evidence for a Proangiogenic Activity of TNF-Related Apoptosis-Inducing Ligand
    Paola Secchiero, Arianna Gonelli, Edvige Carnevale, Federica Corallini, Clara Rizzardi, Serena Zacchigna, Mauro Melato, Giorgio Zauli · 2004 · Neoplasia
62. Immunobiology of Tumor Necrosis Factor Receptor Superfamily
    Tong Zhou, John D. Mountz, Robert P. Kimberly · 2002 · Immunologic Research
63. Pioglitazone Inhibits Growth of Carcinoid Cells and Promotes TRAIL-Induced Apoptosis by Induction of p21waf1/cip1
    Rüdiger Göke, Alexandra Göke, Burkhard Göke, Wafik S. El‐Deiry, Youhai Chen · 2001 · Digestion
64. Mcl-1 and Bcl-xL sequestration of Bak confers differential resistance to BH3-only proteins
    Colin Hockings, Amber E. Alsop, Stephanie C. Fennell, Erinna F. Lee, Walter Douglas Fairlie, Grant Dewson, Ruth M. Kluck · 2018 · Cell Death and Differentiation
65. Redox modulation by plant polyphenols targeting vitagenes for chemoprevention and therapy: Relevance to novel anti-cancer interventions and mini-brain organoid technology
    Maria Concetta Scuto, Maria Laura Ontario, Angela Trovato Salinaro, Isabella Caligiuri, Francesco Rampulla, Vincenzo Zimbone, Sergio Modafferi, Flavio Rizzolio, Vincenzo Canzonieri, Edward J. Calabrese et al. · 2021 · Free Radical Biology and Medicine
66. Trail Receptors: Targets for Cancer Therapy
    Robin C. Humphreys, Wendy Halpern · 2007 · Advances in experimental medicine and biology
67. NKG 2 D regulates production of soluble TRAIL by ex vivo expanded human γδ T cells
    Pouneh Dokouhaki, Nicholas W. Schuh, Betty Joe, Christopher Allen, Sandy D. Der, Ming‐Sound Tsao, Li Zhang · 2013 · European Journal of Immunology
68. Drug Resistance Mediated by AEG-1/MTDH/LYRIC
    Xiangbing Meng, Kristina W. Thiel, Kimberly Kay Leslie · 2013 · Advances in cancer research
69. Rosiglitazone promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP
    Yeoun‐Hee Kim, Eun Mi Jung, Tae-Jin Lee, Sang Hyun Kim, Yung Hyun Choi, Jeen‐Woo Park, Jong‐Wook Park, Kyeong Sook Choi, Taeg Kyu Kwon · 2007 · Free Radical Biology and Medicine
70. Modulation of CCAAT/Enhancer Binding Protein Homologous Protein (CHOP)-dependent DR5 Expression by Nelfinavir Sensitizes Glioblastoma Multiforme Cells to Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)
    Xiaobing Tian, Jiangbin Ye, Michelle Alonso‐Basanta, Stephen M. Hahn, Constantinos Koumenis, Jay F. Dorsey · 2011 · Journal of Biological Chemistry
71. Inducible Resistance of Tumor Cells to Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Receptor 2–Mediated Apoptosis by Generation of a Blockade at the Death Domain Function
    Yang Li, Hong Wang, Zheng Wang, Sharmila K. Makhija, Donald J. Buchsbaum, Albert F. LoBuglio, Robert P. Kimberly, Tong Zhou · 2006 · Cancer Research
72. FLIP as an Anti-Cancer Therapeutic Target
    Jin Kuk Yang · 2008 · Yonsei Medical Journal
73. 2-Deoxy-D-glucose enhances TRAIL-induced apoptosis in human melanoma cells through XBP-1-mediated up-regulation of TRAIL-R2
    Hao Liu, Chen Chen Jiang, Christopher Lavis, Amanda J. Croft, Li Dong, Hsin‐Yi Tseng, Fan Yang, Kwang Hong Tay, Peter Hersey, Xu Dong Zhang · 2009 · Molecular Cancer
74. Development and characterization of recombinant human Fc:OX40L fusion protein linked via a coiled-coil trimerization domain
    Nicholas P. Morris, Carmen Peters, Ryan D Montler, Hong‐Ming Hu, Brendan D. Curti, Walter John Urba, Andrew D. Weinberg · 2007 · Molecular Immunology
75. The sunburn cell revisited: an update on mechanistic aspects
    John M. Sheehan, Antony Richard Young · 2002 · Photochemical & Photobiological Sciences
76. Expression of TRAIL receptors in human autoreactive and foreign antigen-specific T cells
    Uwe Wendling, Henning Walczak, Jan R. Dörr, C.A. Jaboci, Michael Weller, Peter H. Krammer, Frauke Zipp · 2000 · Cell Death and Differentiation
77. NF‐κB and Cytokines
    Dagmar Kulms, Thomas Schwarz · 2006 · Vitamins and hormones
78. FLIP Protein and TRAIL-Induced Apoptosis
    Wilfried Roth, John C. Reed · 2004 · Vitamins and hormones
79. Interleukin-1 Protects Transformed Keratinocytes from Tumor Necrosis Factor-related Apoptosis-inducing Ligand- and CD95-induced Apoptosis but Not from Ultraviolet Radiation-induced Apoptosis
    Gabriele Kothny-Wilkes, Dagmar Kulms, Thomas Anton Luger, Marek Z. Kubin, Thomas Schwarz · 1999 · Journal of Biological Chemistry
80. Effect of NF-κB, survivin, Bcl-2 and Caspase3 on apoptosis of gastric cancer cells induced by tumor necrosis factor related apoptosis inducing ligand
    Liu-Qin Yang, Dian-Chun Fang, Rongquan Wang, Shiming Yang · 2004 · World Journal of Gastroenterology
81. Inhibition of eIF2α dephosphorylation enhances TRAIL-induced apoptosis in hepatoma cells
    Y Teng, M Gao, J Wang, Quanling Kong, Hui Hua, Ting L. Luo, Yangfu Jiang · 2014 · Cell Death and Disease
82. Melatonin sensitizes human malignant glioma cells against TRAIL-induced cell death
    Vanesa Martı́n, Guillermo García‐Santos, Jezabel Rodríguez‐Blanco, Sara C. Zapico, Ana M. Sánchez‐Sánchez, Isaac Antolı́n, M Medina, Carmen Rodrı́guez · 2009 · Cancer Letters
83. Snake venom toxin from vipera lebetina turanicainduces apoptosis of colon cancer cells via upregulation of ROS- and JNK-mediated death receptor expression
    Mi Hee Park, Miran Jo, Dohee Won, Ho Sueb Song, Sang‐Bae Han, Min Jong Song, Jin Tae Hong · 2012 · BMC Cancer
84. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
    Xu Dong Zhang, Jing Wu, Susan K. H. Gillespie, Jodie M. Borrow, Peter Hersey · 2006 · Clinical Cancer Research
85. TRAIL-induced apoptosis in gliomas is enhanced by Akt-inhibition and is independent of JNK activation
    Vinay K. Puduvalli, Deepa Sampath, Janet M. Bruner, Julie R. Nangia, Rui‐Hua Xu, Athanassios P. Kyritsis · 2005 · APOPTOSIS
86. Cancer gene therapy using a novel secretable trimeric TRAIL
    C-Y Kim, Moonsup Jeong, Hajime Mushiake, B-M Kim, W-B Kim, J P Ko, MH Kim, Mimi Kim, T-H Kim, Paul D. Robbins et al. · 2005 · Gene Therapy
87. Chemotherapy and immunotherapy of malignant glioma: molecular mechanisms and clinical perspectives
    Wilfried Roth, Michael Weller · 1999 · Cellular and Molecular Life Sciences
88. Regulation of TRAIL-Induced Apoptosis by Transcription Factors
    Rüdiger Göke, Alexandra Göke, Burkhard Göke, Youhai Chen · 2000 · Cellular Immunology
89. FLIP is frequently expressed in endometrial carcinoma and has a role in resistance to TRAIL-induced apoptosis
    Xavier Dolcet, David Llobet‐Navàs, Judit Pallarés, Montserrat Rué, Joan X. Comella, Xavier Matías‐Guiu · 2005 · Laboratory Investigation
90. Histone deacetylase inhibitors modulate renal cell carcinoma sensitivity to TRAIL/Apo-2L-induced apoptosis by enhancing TRAIL-R2 expression
    Rebecca L. VanOosten, Jill M. Moore, Bahri Karaçay, Thomas S. Griffith · 2005 · Cancer Biology & Therapy
91. CD95 Stimulation Results in the Formation of a Novel Death Effector Domain Protein-containing Complex
    Inna N. Lavrik, Thomas Mock, Alexander Golks, Julia C. Hoffmann, Simone Baumann, Peter H. Krammer · 2008 · Journal of Biological Chemistry
92. Delivery of apoptotic signal to rolling cancer cells: A novel biomimetic technique using immobilized TRAIL and E‐selectin
    Kuldeepsinh Rana, Jane L. Liesveld, Michael R. King · 2008 · Biotechnology and Bioengineering
93. Caspase-8 dependent trail-induced apoptosis in cancer cell lines is inhibited by vitamin C and catalase
    Isabel Perez-Cruz, Juan M. Cárcamo, David W. Golde · 2006 · APOPTOSIS
94. Differential induction of apoptosis by tumor necrosis factor-related apoptosis-inducing ligand in human ovarian carcinoma cells
    Denis A. Lane, A. CARTIER, Sylvain L’Espérance, Marceline Côté, Claudine Rancourt, Alain Piché · 2004 · Gynecologic Oncology
95. Fas-ligand (CD178) and TRAIL synergistically induce apoptosis of CD40-activated chronic lymphocytic leukemia B cells
    Frank Dicker, Arnon Philip Kater, Tetsuya Fukuda, Thomas J. Kipps · 2004 · Blood
96. TNF-related apoptosis-inducing ligand mediates human neuronal apoptosis: links to HIV-1-associated dementia
    Lisa A. Ryan, Hui Peng, David A. Erichsen, Yunlong Huang, Yuri Persidsky, You Zhou, Howard Eliot Gendelman, Jialin Zheng · 2004 · Journal of Neuroimmunology
97. Regulation of Akt by EGF-R inhibitors, a possible mechanism of EGF-R inhibitor-enhanced TRAIL-induced apoptosis
    Sang‐Youel Park, Dai‐Wu Seol · 2002 · Biochemical and Biophysical Research Communications
98. Infection of human primary hepatocytes with dengue virus serotype 2
    Lukkana Suksanpaisan, Arturo Cabrera‐Hernandez, Duncan Richard Smith · 2007 · Journal of Medical Virology
99. HIV infection increases HCV-induced hepatocyte apoptosis
    Jae Young Jang, Run–Xuan Shao, Wenyu Lin, Ethan M. Weinberg, Woo Jin Chung, Wei Lun Tsai, Hong Zhao, Kaku Goto, Leiliang Zhang, Jorge Méndez-Navarro et al. · 2010 · Journal of Hepatology
100. Cleavage of p53-Vimentin Complex Enhances Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Mediated Apoptosis of Rheumatoid Arthritis Synovial Fibroblasts
     Xinwen Yang, Jianhua Wang, Cunren Liu, William E. Grizzle, Shaohua Yu, Shuangqin Zhang, Stephen Barnes, William J. Koopman, John D. Mountz, Robert P. Kimberly et al. · 2005 · American Journal Of Pathology